By BY DENISE GRADY from NYT Health Moderna is the second company to report preliminary results from a large trial testing a vaccine. But there are still months to go before it will be widely available to the public. https://ift.tt/2II31F4
16 Kasım 2020 Pazartesi
Early Data Show Moderna’s Coronavirus Vaccine Is 94.5% Effective
By BY DENISE GRADY from NYT Health Moderna is the second company to report preliminary results from a large trial testing a vaccine. But there are still months to go before it will be widely available to the public. https://ift.tt/2II31F4
Kaydol:
Kayıt Yorumları (Atom)
Routine Childhood Vaccinations in the U.S. Slipped During the Pandemic
By BY BENJAMIN MUELLER AND JAN HOFFMAN from NYT Health Nationwide, the number of kindergartners with the required shots fell below the targ...
-
By BY EMILY ANTHES from NYT Health The F.D.A. authorized a breath-based test made by a small Texas company, which said it hoped that mobile...
-
By BY CARL ZIMMER from NYT Health https://ift.tt/2IHUMZY
-
https://ift.tt/2qR64Cz
Hiç yorum yok:
Yorum Gönder